Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/18316568

Clin. Cancer Res. 2008 Mar 1 14 5 1446-54

Download in:

View as

Triples

General Info

PMID
18316568